Clinical Trial Update: Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating chitosan to pharmacologically manipulate AGE levels in prostate cancer was terminated; results were posted on 2025-06-10.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Chitosan (Chitosan)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-06-10